Application 206097
- Type
- ANDA
- Sponsor
- ZYDUS PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LINEZOLID | LINEZOLID | TABLET;ORAL | 600MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 68382-413 | Linezolid | Linezolid | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-413 | Linezolid | Linezolid | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-413 | Linezolid | Linezolid | Zydus Pharmaceuticals USA Inc. | ANDA | Current |
| 70771-1111 | Linezolid | Linezolid | Cadila Healthcare Limited | ANDA | Current |
| 70771-1111 | Linezolid | Linezolid | Zydus Lifesciences Limited | ANDA | Current |
| 70771-1111 | Linezolid | Linezolid | Cadila Healthcare Limited | ANDA | Current |
| 70771-1111 | Linezolid | Linezolid | Cadila Healthcare Limited | ANDA | Current |